381 related articles for article (PubMed ID: 23954737)
41. Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia.
Kontis D; Theochari E; Kleisas S; Kalogerakou S; Andreopoulou A; Psaras R; Makris Y; Karouzos C; Tsaltas E
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1333-41. PubMed ID: 20691745
[TBL] [Abstract][Full Text] [Related]
42. Reduced cognitive control of a visually bistable image in schizophrenia.
McBain R; Norton DJ; Kim J; Chen Y
J Int Neuropsychol Soc; 2011 May; 17(3):551-6. PubMed ID: 21385517
[TBL] [Abstract][Full Text] [Related]
43. Prefrontal lobe dysfunction predicts treatment response in medication-naive first-episode schizophrenia.
van Veelen NM; Vink M; Ramsey NF; van Buuren M; Hoogendam JM; Kahn RS
Schizophr Res; 2011 Jul; 129(2-3):156-62. PubMed ID: 21497488
[TBL] [Abstract][Full Text] [Related]
44. Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study.
Zhang XY; Chen DC; Xiu MH; Haile CN; He SC; Luo X; Zuo L; Rosenheck R; Kosten TA; Kosten TR
Psychol Med; 2013 Aug; 43(8):1651-60. PubMed ID: 23149169
[TBL] [Abstract][Full Text] [Related]
45. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia.
Lewis DA; Cho RY; Carter CS; Eklund K; Forster S; Kelly MA; Montrose D
Am J Psychiatry; 2008 Dec; 165(12):1585-93. PubMed ID: 18923067
[TBL] [Abstract][Full Text] [Related]
46. [The frequency-contrast sensitivity of visual stimulus perception in patients with schizophrenia with the therapy of atypical and typical antipsychotic drugs].
Shoshina II; Shelepin IuE; Semenova NB
Fiziol Cheloveka; 2014; 40(1):43-8. PubMed ID: 25272767
[TBL] [Abstract][Full Text] [Related]
47. [The Spatial-Frequency Characteristics of the Visual System in Schizophrenia].
Shoshina II; Shelepin YE; Vershinina EA; Novikova KO
Fiziol Cheloveka; 2015; 41(3):29-40. PubMed ID: 26237946
[TBL] [Abstract][Full Text] [Related]
48. Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia.
Tenjin T; Miyamoto S; Miyake N; Ogino S; Kitajima R; Ojima K; Arai J; Teramoto H; Tsukahara S; Ito Y; Tadokoro M; Anai K; Funamoto Y; Kaneda Y; Sumiyoshi T; Yamaguchi N
Hum Psychopharmacol; 2012 Jan; 27(1):90-100. PubMed ID: 22278973
[TBL] [Abstract][Full Text] [Related]
49. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
[TBL] [Abstract][Full Text] [Related]
50. Improvement of cognitive flexibility and cingulate blood flow correlates after atypical antipsychotic treatment in drug-naive patients with first-episode schizophrenia.
Pardo BM; Garolera M; Ariza M; Pareto D; Salamero M; Valles V; Delgado L; Alberni J
Psychiatry Res; 2011 Dec; 194(3):205-211. PubMed ID: 22044531
[TBL] [Abstract][Full Text] [Related]
51. Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophrenia.
Sun L; Castellanos N; Grützner C; Koethe D; Rivolta D; Wibral M; Kranaster L; Singer W; Leweke MF; Uhlhaas PJ
Schizophr Res; 2013 Nov; 150(2-3):519-25. PubMed ID: 24016727
[TBL] [Abstract][Full Text] [Related]
52. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
53. Visual-perceptual dysfunctions are possible endophenotypes of schizophrenia: evidence from the psychophysical investigation of magnocellular and parvocellular pathways.
Kéri S; Kelemen O; Janka Z; Benedek G
Neuropsychology; 2005 Sep; 19(5):649-656. PubMed ID: 16187883
[TBL] [Abstract][Full Text] [Related]
54. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
[TBL] [Abstract][Full Text] [Related]
55. Plasma total antioxidant status and cognitive impairments in schizophrenia.
Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
[TBL] [Abstract][Full Text] [Related]
56. Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia.
Herbener ES; Hill SK; Marvin RW; Sweeney JA
Am J Psychiatry; 2005 Sep; 162(9):1746-8. PubMed ID: 16135639
[TBL] [Abstract][Full Text] [Related]
57. Cognition impairment in schizophrenia patients with tardive dyskinesia: association with plasma superoxide dismutase activity.
Wu JQ; Chen DC; Tan YL; Tan SP; Wang ZR; Xiu MH; Yang FD; Zhang XY
Schizophr Res; 2014 Jan; 152(1):210-6. PubMed ID: 24325977
[TBL] [Abstract][Full Text] [Related]
58. Compromised late-stage motion processing in schizophrenia.
Chen Y; Levy DL; Sheremata S; Holzman PS
Biol Psychiatry; 2004 Apr; 55(8):834-41. PubMed ID: 15050865
[TBL] [Abstract][Full Text] [Related]
59. Do deficits in the magnocellular priming underlie visual derealization phenomena? Preliminary neurophysiological and self-report results in first-episode schizophrenia patients.
Núñez D; Oelkers-Ax R; de Haan S; Ludwig M; Sattel H; Resch F; Weisbrod M; Fuchs T
Schizophr Res; 2014 Nov; 159(2-3):441-9. PubMed ID: 25239127
[TBL] [Abstract][Full Text] [Related]
60. Early stage vision in schizophrenia and schizotypal personality disorder.
O'Donnell BF; Bismark A; Hetrick WP; Bodkins M; Vohs JL; Shekhar A
Schizophr Res; 2006 Sep; 86(1-3):89-98. PubMed ID: 16829048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
